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Abstract
The structure and function of the C-terminal domain of the murine leukemia virus Surface protein (MuLV SU) is not well defined.
Passage of chimeric ecotropic-amphotropic MuLV viruses with junctions within the SU C-terminus results in the selection of specific point
mutations which improve virus viability and Env function. Point mutations were characterized that alter the conformation of the SU/TM
heterodimers on the viral particles. Mutation of position E311 within the Moloney MuLV SU protein alters the conformation of the TM
protein and its recognition by antibody 42-114 in immunoprecipitation reactions. Mutation of either G541R in the amphotropic 4070A TM,
V421M in the 4070A SU, or deletion of S39 and P40 at the N-terminus of the M-MuLV SU results in an irreversible cold-sensitive
phenotype at 4°C. This loss of viral titer can be restored by incorporating V421M plus G541R or del S39 P40 plus G541R in cis within
the SU/TM.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The conformation of the retroviral Envelope (Env) pro-
tein is considered to be metastable, similar to hemagglutin
(Carr et al., 1997; Carr and Kim, 1993). The limited struc-
tures of the Friend-murine leukemia virus (Fr-MuLV) re-
ceptor-binding domain (RBD) (1aol.pdb) (Fass et al., 1997)
and the ectodomain of Moloney MuLV (M-MuLV)
(1mof.pdb) (Fass et al., 1996) reveal interesting features of
the isolated domains but cannot address the conformation-
dependent contacts during viral entry. General regions of
Env, such as the N-terminus of Surface (SU) Env (Bae et al.,
1997; Lu and Roth, 2001), the RBD (Battini et al., 1995,
1996; MacKrell et al., 1996; Tailor and Kabat, 1997; Tailor
et al., 2000), the proline-rich region (PRR) (Lavillette et al.,
1998; Wu et al., 1998; Zavorotinskaya and Albritton,
1999b), the C-terminus of SU (Barnett et al., 2001; Gray
and Roth, 1993; Lavillette et al., 2001; Sanders, 2000), and
the Env transmembrane (TM) protein (Berkowitz and Goff,
1993; Li et al., 1996; Ragheb et al., 1995; Rein et al., 1994;
Thomas et al., 1997; Thomas and Roth, 1995; Yang and
Compans, 1997; Zhao et al., 1998; Zhu et al., 1998) have
been studied for their contributions to Env function.
The C-terminus of SU is well conserved among MuLVs.
Contacts within the SU C-terminus are critical for SU-TM
assembly and stability (Gray and Roth, 1993; Pinter et al.,
1997; Rothenberg et al., 2001). Interactions between SU
and TM are mediated by both noncovalent and covalent
bonds. A disulfide bond between SU and TM is mediated by
cysteines in the CWLC motif of SU and the CX6CC motif
of TM (Pinter et al., 1997). In addition to a role in the
stabilization of SU and TM, results of recent experiments
suggest that the C-terminus of SU plays a pivotal role
toward the achievement of viral–cell fusion (Barnett et al.,
2003, 2001; Lavillette et al., 2001, 2002; Sanders, 2000).
Rearrangement of the SU–TM disulfide bond is proposed to
facilitate structural conformational changes required for fu-
sion (Sanders, 2000). A model of the SU–C-terminus inter-
action with the remainder of Env proposes that alternate
contacts between SU and TM form upon receptor binding
(Barnett et al., 2001), which lead to fusion. Postreceptor
binding and interactions between the N- and C-terminus of
SU are required for viral fusion to occur (Barnett et al.,
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2003, 2001; Lavillette et al., 2001, 2002). At least one of
these interactions has been further defined to occur between
the SU N-terminus and a conserved disulfide loop in the
C-terminus of SU (Lavillette et al., 2001).
In the present study, a set of replication-impaired chi-
meric Envs constructed between M-MuLV and 4070A (EA
series) (Peredo et al., 1996) were used as tools to identify
cooperative interactions between four regions of SU and
TM. In this study, mutations N261I (RBD) and E311V (SU
C-terminus) cooperate in terms of viral titer and additionally
alter the conformation of SU-associated TM. Combinatorial
cloning of mutations del S39 P40 (SU N-terminus), V421M
(SU C-terminus), and G541R (TM ectodomain) identified
cold-sensitive mutants of MuLV Env defective for viral
entry. Cold-sensitive mutants of P22 coat protein were char-
acterized as incompletely folded precursors and were theo-
rized to be important for achieving multiple conformations
(Galisteo et al., 1995). The cold-sensitive phenotype of
MuLV Env mutants supports the existence of multiple con-
formations of the metastable Env during viral fusion.
Results
Generation of EA chimeric virus producer lines
A series of chimeric MuLV Env proteins were previ-
ously generated encoding the receptor-binding domain of
M-MuLV fused with the C-terminus of 4070A Env protein
(EA series) (Peredo et al., 1996) within an infectious pro-
viral backbone. The positions of the junctions of M-MuLV
and 4070A-MuLV Env proteins are outlined in Fig. 1A. The
utilization of replication-competent viruses allows for the
selection and enrichment of mutations within a viral popu-
lation that are advantageous for viral viability. Isolation of
these mutations is facilitated through passage of the virus in
canine D17 osteosarcoma cells, reducing the potential of
recombination with endogenous murine retroviruses (Lu
and Roth, 2001; O’Reilly and Roth, 2000; Peredo et al.,
1996). To confirm the viral fitness observed in NIH/3T3
cells, the chimeric EA Env viruses were passaged in D17
cells, which stably expressed the ecotropic receptor,
MCAT-1 (pJET cells) (Albritton et al., 1989; O’Reilly and
Roth, 2000). Plasmid DNA encoding the EA chimera series
was introduced into D17/pJET cells by the DEAE-Dextran
method (McCutchan and Pagano, 1968) (Fig. 1B). Virus
viability was assessed by the release of reverse transcriptase
into the culture supernatant. Chimeras EA4 and EA8 pos-
sess junctions that correspond to the RBD and the fusion
peptide region of TM (Fig. 1A). Chimeras EA4 and EA8
displayed replication kinetics (Fig. 1B, lanes 2 and 6) as
well as viral titers (Table 1: 9.0  104 and 6.4  104,
respectively) equivalent to wild-type (wt) M-MuLV (Fig.
1B, lane 7; Table 1: 8.0  104). Similar to our analyses of
the AE series (O’Reilly and Roth, 2000), chimeras possess-
ing junctions in the C-terminus of SU (EA5, EA6, and EA7)
spread slower than the wt M-MuLV control. Chimeras EA5
and EA7 showed a delay of 13 and 26 days, respectively
(Fig. 1B, lanes 3 and 5). Reverse-transcriptase activity was
not released in the first transient expression assay of EA6
(Fig. 1B, lane 4); however, a low level of reverse-tran-
scriptase signal could be detected in a second independent
assay (Fig. 1B, lane 11) at day 40. These results parallel
those observed in NIH/3T3 cells (Peredo et al., 1996), with
more pronounced delays observed in D17 cells.
Passage of retroviruses allows for the generation of qua-
sispecies from which adaptive variants can be selected.
After the initial passage of the EA5 chimera, the resultant
virus spread at a similar rate as the wt M-MuLV control,
releasing RT activity into the culture supernatant by day 2
(data not shown). In contrast, the populations of EA6 and
EA7 chimera maintained delayed kinetics and were not
RT-positive until days 5 and 9, respectively (data not
shown). The populations of EA6 and EA7 isolated at day 15
of the second round of infection, however, replicated with
kinetics equivalent to the wt M-MuLV. The env genes of
these in vivo selected chimeras were sequenced to identify
the adaptive second-site mutations. This approach has been
productive in defining domain interactions and critical res-
idues within the SU/TM complex (Lu and Roth, 2003;
O’Reilly and Roth, 2000).
Fig. 1. Time course of infection of chimeric EA env series in D17/MCAT-1
(pJET) cells. (A) Linear schematic of the SU and TM proteins includes the
junctions and amino acid joining sites in the ecotropic M-MuLV and
amphotropic 4070A Envs as previously described. SU domains of VRA,
VRC, VRB, and PRR are additionally shown as reference points for the
junctions. (B) 0.5-g samples of plasmid DNA expressing proviral con-
structs of the chimeric EA envelope proteins and the wt M-MuLV were
introduced into 105 cells per 60-mm-diameter plates by the DEAE-Dextran
method (McCutchan and Pagano, 1968), allowing for transient expression
of the virus. Supernatant media were assayed for the expression of reverse
transcriptase, as described under Materials and methods. Constructs are
indicated at the top of each lane; lanes 1–7 and lanes 8–14 represent
independent transfections of each plasmid DNA.
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Second-site changes are located in multiple domains of
SU and TM
Based on the improved kinetics of infection, low molec-
ular weight HIRT DNA (Hirt, 1967) was isolated from the
viral populations of EA5, EA6, and EA7 viruses; the env
gene was PCR-amplified and each population was se-
quenced. Second-site changes were observed in all se-
quenced populations and occurred throughout SU and TM
(Table 2). In the viral population of EA5, two changes were
observed within the ecotropic portion of the SU protein
chimera. A60T is within the N-terminal SU 2 strand. The
second change, E311K, occurred in the SU C-terminus
adjacent to the PRR. Two changes, V58A (2) and I255T
(9), were not apparent until individual clones were ana-
lyzed and are thus minor species within the total population.
Two viral populations of EA6 were sequenced. The first
population corresponds to the virus isolated after transient
expression of the proviral plasmid (Fig. 1, lane 11). Two
second-site changes, N261I and E311V, were identified
within the ecotropic SU protein. Similar to the minor change
I255T (EA5), N261I is located near the C-terminus of the
receptor-binding domain on the 9 strand. Position E311
was previously found altered in the EA5 chimeric virus
(Table 2). The secondary passage of EA6 that displayed
near wt kinetics was also analyzed. While both second-site
changes, N261I and E311V, observed in the first EA6 pop-
ulation were maintained, a new mutation, G541R, was de-
tected. This mutation mapped to the amphotropic TM and is
homologous to M-MuLV residue G552, located at the top of
the TM ectodomain structure (1mof.pdb; see Discussion)
(Fass et al., 1996).
Two independent EA7 viral populations (denoted A and
B) derived from transient expression assays were analyzed
(Table 2). A single mutation was observed in each popula-
tion. Population A contained a deletion of amino acids S39
and P40 within the N-terminus of SU, and population B
encoded V421M in the SU C-terminus. The secondary pas-
sages of the EA7 viral populations with improved replica-
tion kinetics were also sequenced. Remarkably, both popu-
lations independently selected for the same second-site
mutation, G541R, while maintaining their original muta-
tions (del S39 P40 and V421M). This is the identical posi-
tion found altered in the TM protein of the EA6 population
(Table 2). The isolation of mutations at position E311 and
G541 in multiple Env chimeras identify these single amino
acids as key regulatory positions within the SU/TM com-
plex. The functions of these mutations were further studied.
Effects of E311 second-site changes
The occurrence of second-site changes at amino acid
E311 in EA5 and EA6 viral populations suggested this
position is critical for restoring correct Env function. In the
EA5 population, the negatively charged glutamic acid was
substituted with a positively charged lysine. In contrast, in
the EA6 population the glutamic acid was substituted with
an aliphatic valine. Reverse substitutions of E311K in EA6
and E311V in EA5 were tested to determine if a substitution
at this position posed a strong bias for a particular amino
acid.
The E311V/K substitutions were introduced into Env
expression constructs. The utilization of a viral vector sys-
tem allows for direct assessment of the effect of a mutation
based on a single round of infection and facilitates the
determination of viral titer through the transfer of a marker
gene. Virus with delayed kinetics of infection in a replica-
tion-competent system requiring the acquisition of second-
site mutations for improved fitness would thus have a low
viral titer using a single round of infection within a viral
vector. The titers of viruses bearing Envs with second-site
changes were compared with the parental Env chimeras
(Table 1). Entry was scored based on the number of -gal-
expressing D17/pJET cells/ml, 48 h postinfection. The wt
M-MuLV had a titer of 8.0 104, whereas the parental EA5
Table 2
Second-site mutations isolated after viral passage
Env Initial isolate Secondary passage
EA5 A60T, E311K, (V58A, I255T)a N.D.b
EA6 N261I, E311V N261I, E311V, G541R
EA7 A: del S39 P40 del S39 P40, G541R
B: V421M V421M, G541R
a Minor sequence in population indicated in parentheses.
b Not determined.
Table 1
Viral titers of EA Env chimeras
Chimeraa Constructb Titerc
M-MuLV 8.0 6.0  104
EA4 9.0 4.5  103
EA5
Parent 10
A60T 10
E311K 2.8 1.8  103
E311V* 7.1 1.6  103
A60T/E311K 1.8 0.7  103
EA6
Parent 10
N261I 10
E311K* 10
E311V 3.8 1.8  103
N261I/E311V 1.2 0.2  104
EA8 6.4 4.0  103
a MuLV-bearing envelope chimeras as indicated.
b Second-site changes isolated in chimeric populations with the excep-
tion of (*), which were generated in vitro.
c Vector DNA encoding lacz plus each env was translently expressed in
D17/gag-pol cells. Culture supernatent, collected within 48 h posttransfec-
tion, was used to infect D17/pJET cells. Titer determinations are based on
number of D17/pJET cells scoring positive for lacz expression/ml; values
represent means  standard deviations of at least three independent ex-
periments.
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Env resulted in no vector transduction. The initial population
of EA5 encoded both A60T and E311K. EA5 bearing A60T
had no measurable titer. Substitution of the in vivo selected
E311K into EA5 restored titer to the EA5 Env to 2.8  103.
The introduction of A60T in the E311K backbone resulted in
a slight reduction of viral titer over E311K alone, with a
resultant titer of 1.8  103. Surprisingly, the E311V substitu-
tion, selected within EA6, restored the titer of EA5 to 7.1 
103, a small, but reproducible improvement (2.5-fold) in titer
over the E311K mutation. In a replication-competent proviral
expression assay, three independent replicates of virus encod-
ing the Env E311V mutation spread with faster kinetics than
virus encoding the Env E311K mutation (data not shown).
These results confirm the titer studies, indicating that the
E311K substitution restores function to the EA5 chimeric Env
better than the in vivo selected E311V.
In contrast, the EA6 Env chimera was much more selec-
tive at position E311 for the substitutions that restored Env
function. The parental EA6 has no titer in this single round
of infection (Table 1). Substitution of E311V in EA6 re-
stored titer to 3.8  103 (Table 1). Interestingly, EA6 virus
containing E311K was not infectious (Table 1). This may be
due to the longer hydrocarbon chain of the lysine or to the
charge reversal itself.
The Env expression level within each chimeric Env back-
bone was examined to determine if there was a correlation with
viral titer. Fig. 2 shows the results of immunoprecipitation and
Western blot analyses for viral SU and TM expression. Viral
particles were pelleted through a sucrose cushion and viral-
associated SU was analyzed by Western blotting (Fig. 2). From
this analysis, the level of SU associated with the virus does not
correspond with the viral titer (Fig. 2A, left panel). The paren-
tal EA5 virus, which has no titer, has equivalent levels of SU
protein as the wt M-MuLV and the EA5 bearing E311K, both
of which are infectious. Substitution of A60T within the EA5
Env increased the amount of SU associated with the virus (lane
2), yet maintained a background level of viral titer (Table 1).
The mutation at E311 to V increased the proportion of SU
associated with the virus. The enhanced level of viral-associ-
ated E311V (lane 4) in comparison to E311K (lane 3) corre-
lates with the higher titer observed in infectivity experiments
(Table 1) and transient spreading assay (data not shown).
Within the EA6 chimeras, a similar lack of correlation
between the SU level and the viral titer was observed (Fig. 2A,
right panel). EA6 chimera bearing E311V (lane 10), with a titer
of 3.8  103, contained the least viral-associated SU. Despite
a lack of viral titer, the substitution of a lysine at position E311,
within the EA6 Env, results in an enhanced level of SU protein
(lane 11) in comparison to the valine substitution (lane 10).
This result suggests that the identity of the amino acid at
position E311 is critical for Env function during viral entry.
Similar to the EA5 chimera bearing A60T, the EA6 chimera
bearing N261I (lane 9) has no detectable titer (Table 1) and
high levels of SU protein. Within these SU proteins, there is a
large variation of SU processing. It is interesting to note that
the predominant SU product for both the EA5 and the EA6
parental chimeras migrates slower than the chimeras recon-
structed with the point mutations or the wt MuLV. This indi-
cates that the level of glycan processing and posttranslational
modifications of the SU proteins can influence the titer of the
virus-associated SU protein.
Although the level of viral-associated SU did not corre-
late with the viral titer, insights into this phenomenon were
obtained by analysis into the viral-associated TM. The SU
and TM are expressed as a precursor protein that is proteo-
lytically processed during transport to the cell surface by a
Fig. 2. Effect of second-site changes in EA5 and EA6 chimeric envelope proteins. (A) Western blot analysis of viral SU protein following transient expression;
1-ml aliquots of 5-ml viral supernatant were spun through 0.2 ml 20% sucrose cushions at 16K g for 45 min. Viral pellets were then resuspended and separated
on a 10–20% SDS-PAGE and transferred onto PVDF membranes. SU Env proteins were visualized by immunostaining with goat polyclonal antibody to SU
(79S-842), followed by rabbit -goat-HRP secondary antibody and chemiluminescence (Pierce). (B) Immunoprecipitation analyses of viral TM. 5 ml viral
supernatants were collected 24 h postmetabolic labeling, applied to 20% sucrose cushions, and spun at 35K rpm in a SW41 ultracentrifuge rotor for 4 h. Viral
pellets were resuspended in 1 ml PLB. Virus corresponding to one-fifth plate was incubated with 50 l antibody 42–114 (anti-TM), followed by incubation
with Pansorbin. Samples were separated on a 17.5% SDS–PAGE. Autoradiogram signals correspond to one-tenth of the viral preparation. Left panel: parental
EA5 and selected second-site changes within the EA5 backbone (lanes 1 to 7); right panel: parental EA6 and selected second-site changes in the EA6
backbone (lanes 8 to 14). Molecular weight markers are indicated at the left of each panel.
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host protease within the trans-Golgi. Under optimal condi-
tions, the ratio of SU to TM should be 1:1. However, due to
shedding, the level of SU associated with virions could be
lower than the level of TM. Experimentally, however, the
level of TM associated with the parental EA5 and EA6
virions was far below that detected for the SU protein.
Following 35S-labeling, the TM viral proteins of the Env
mutants were analyzed by immunoprecipitation with the
TM monoclonal antibody 42-114 (Fig. 2B). For the EA5
Env, the level of viral-associated SU protein was equivalent
to wt M-MuLV; however, the level of TM protein was
barely detectable under conditions that wt TM proteins are
readily detected. The low level of viral TM in the parental
EA5 does not correlate with the near wt signal seen for the
SU protein. This suggests that the epitope recognized by
TM antibody 42-114 is compromised in both EA5 and EA6.
Substitution of either a K or V at position E311 results in an
enhanced signal of viral-associated TM, independent of the
chimeric backbone (Fig. 2B, lanes 3–4 and 10–11). Within
the EA5 and EA6 backbones, this could be interpreted as
restoring a conformation recognized by 42–114. Incorpora-
tion of A60T plus E311K into EA5 decreased the TM signal
compared to E311K alone, with a concomitant appearance
of SU-TM precursor (Figs. 2A and B, lane 5).
Within the EA6 virus, the E311V was isolated in combi-
nation with N261I. The combination of N261I and E311V
resulted in high viral titer (Table 1: 1.2 104) and additionally
yielded large syncytia (L. O’Reilly and M.J. Roth, submitted
for publication). The cooperative effect of these two mutations
within SU on the structure of the TM was therefore analyzed.
EA6 Env bearing N261I and E311V yielded a large level of
processed SU (Fig. 2A, lane 12). The levels of TM, however,
are disproportionately increased for the N261I/E311V mutant
(Fig. 2B, lane 12) in comparison to the single mutants N261I
(Fig. 2B, lane 9) and E311V (Fig. 2B, lane 10). This result
suggests that for this double combination, a conformation rec-
ognizable by TM antibody 42–114 may be restored that is very
similar to that of M-MuLV.
Analysis of EA7 second-site changes: cold sensitivity and
Env expression
Two independent passages of the virus bearing EA7 Env
resulted in Env with either the second-site combinations of
Fig. 3. Effect of Env substitutions in chimeric EA7 on Env interactions. (A) Expression analyses of second-site changes in EA7 chimeric envelopes. Plasmids
that express chimeric envelope were transiently transfected into either D17 cells or D17/gag-pol cells using lipofectamine protocol as described under
Materials and methods. Twenty-four hours posttransfection, fresh media were applied to cells for subsequent viral collection. Virus was purified by
centrifuging 1 ml of culture supernatant through 0.2 ml 20% sucrose at 16K g for 45 min (Wu et al., 1998) and analyzed by SDS-PAGE. Proteins were
transferred to PVDF membranes using a liquid transfer system. Polyclonal antibody 80S-019 (anti-SU antiserum) (Microbiological Associates) was used to
detect Env proteins on Western blots. Polyclonal antibody 79S-287 (Microbiological Associates) was used to detect capsid proteins on Western blots. Left
panel: transient expression of EA7 chimeric envelopes in envelope expression vector in D17/gag-pol cells (lanes 1 to 7); right panel: transient expression
of EA7 chimeric envelopes in the proviral backbone in D17 cells (lanes 8 to 14). (B) Effect of centrifugation conditions on viral SU. Transiently expressed
viruses were subjected to varying centrifugal treatments prior to Western blot analyses. Top and middle panels: replicate 1-ml aliquots of virus were
centrifuged through 0.2 ml 20% sucrose at 16K g at either 25 or 4°C; top panel: transient expression of EA7 chimeric Envs in proviral expression plasmids;
middle panel: transient expression of EA7 chimeric Envs in envelope expression vector. Bottom panel: 1-ml aliquots of virus from same transient expression
experiment as in middle panel were spun at 3K g for 6 h in the absence of sucrose.
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del S39 P40 plus G541R or the V421M plus G541R (Table
2). Titer analysis reconstituting second-site changes within
an EA7 backbone revealed an interesting cold-sensitivity
(Table 3). Second-site changes were evaluated either in the
Env expression vector pHIT (top panel) or within the pro-
viral parental backbone (bottom panel); both systems pro-
vided comparable results. Independent of plasmid back-
bone, parental virus EA7 did not have a measurable titer,
consistent with the delayed replication kinetics observed in
transient spreading assays (Fig. 1B). If the virus was col-
lected and immediately used for infection at 37°C, G541R
was capable of restoring the EA7 titer to a moderate titer
between 6.6  102 and 1.7  103 (Table 3). Either point
mutation V421M or del S39 P40 restored titer to levels
approximating the wt 4070A and M-MuLV virus. Maximal
titer was obtained by combining V421M with G541R or del
S39 P40 with G541R, resulting in titers of 6.9 104 and 9.6
 104, respectively (Table 3).
Surprisingly, an effect on viral titers was observed de-
pending on temperature treatment of virus prior to use in
infection. Virus was collected from the producer cells and
held on ice (4°C) for 30 min prior to infection at 37°C. EA7
Env reconstructed with either V421M alone, G541R alone,
or del S39 P40 displayed an irreversible cold-sensitivity.
The titer of V421M-bearing virus held at 4°C decreased to
1.3  102, representing a 2-log decrease from titer if used
immediately (Table 3; 37°C; 4.7  104). Similarly, the titer
of G541R-bearing virus decreases to 8.3  101 if held at
4°C prior to infection, representing a 20-fold decrease over
37°C viral titer (Table 3; 37°C: 1.7  103). This cold-
sensitivity was not observed when the mutations were com-
bined. EA7 virus bearing the combination of V421M plus
G541R or del S39 P40 plus G541R retained titers at 4°C
equivalent or better than those obtained at 37°C (Table 3:
1.1  105 and 9.9  104, respectively). This parallels the
selection of the mutations in tissue culture, where G541R
was selected in both populations as a stabilizing mutation
upon secondary passage of the individual EA7/V431M and
EA7/del S39 P40 virus (Table 2). Control M-MuLV and
4070A-MuLV viral titers were not sensitive to variation
when preincubated at 25 and 4°C. Viral titers remained
fairly constant for the del S39 P40, V421M, and G541R
viruses if held at 25°C prior to infection (Table 3: 5.5 104,
2.6  104, and 8.8  102, respectively) in comparison to
37°C viral titers.
The stabilizing phenotype of incorporating G541R in
combination with either the del S39 P40 or the V421M
mutations was corroborated with increased association of
SU on viral particles. The levels of Env protein incorporated
in the viral particles were examined by Western blots. For
each single mutant (Fig. 3A, lanes 3–4 and 10–11), the
levels of SU on the virus detectable with SU polyclonal
antibody 80S-019 are low, while the double combination
mutants maintain a higher level of SU on the virus (Fig. 3A,
lanes 5 and 12). However, this stabilizing effect is not
through decreased SU shedding. Immunoprecipitation of
35S-labeled proteins in the media (total supernatant) fol-
lowed by Western blot analysis yielded SU proteins at
equivalent proportions as those found on the viral particles
(data not shown). In addition, the cold-sensitive phenotype
is also not the result of SU shedding at the lower tempera-
ture. Virus was isolated from culture supernatants and sub-
jected to centrifugation at varying conditions to analyze SU
association with viral particles (Fig. 3B). Varying the cen-
trifugal speed from 3K g for 6 h to 16K g for 45 min at 4°C
did not change the viral association of SU (Fig. 3B, bottom
panel). These conditions distinguished an entry intermedi-
ately sensitive to shedding (C.-W. Lu and M.J. Roth, manu-
script in preparation). In addition, centrifugation of viral
preparations at 16K g for 45 min at either 25 or 4°C resulted
in similar levels of SU associated with viral particles (Fig.
3B, middle and bottom panels). The minor variation of SU
Table 3
Effects of temperature on viral titer
Vector Construct Titerd
37°C 4°Ca 25°Cb
pHITc EA7/V421M 4.7 104 1.3  102 2.6  104
EA7/G541R 1.7 103 8.3  101 8.8  102
EA7/V421M/G541R 6.9 104 1.1  105 6.6  104
EA7 10 10 10
M-MuLV 9.4 104 1.1  105 7.5  104
4070A-MuLV 2.6 104 2.7  104 1.7  104
pNCA-C EA7/del S39 P40 7.8 104 2.7  102 5.5  104
EA7/G541R 6.6 102 6.1  101 4.6  102
EA7/del S39 P40/G541R 9.6 104 9.9  104 9.6  104
EA7 10 10 10
M-MuLV 9.6 104 1.0  105 9.0  104
4070A-MuLV 8.2 104 8.1  104 8.2  104
a Viral stocks were incubated on ice for 30 min prior to infection.
b Viral stocks were incubated at room temperature for 30 min prior to infection.
c Chimeric env genes were reconstructed into pHIT 123-Nhe, wild-type M-MuLV, and 4070A were expressed from pHIT123 and pHIT456, respectively.
d Infectious units/ml.
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association would not accommodate the 100-fold variation
in viral titer. The loss of viral titer upon incubation at 4°C
therefore cannot be due to SU shedding but rather to the
stabilization of a conformation that cannot be reversed by a
temperature shift to the permissive temperature. The fact
that this temperature sensitivity is observed for mutations at
the SU N-terminus (del S39 P40), the SU C-terminus
(V421M), and the TM ecodomain (G541R) indicates the
complexity of the SU/TM interactions and conformations
required for productive viral entry.
Discussion
The passaging of replication-impaired chimeric-envel-
oped MuLVs has identified regions of SU and TM critical
for envelope function during viral entry which otherwise
may not have been targeted for mutational analyses. The
results of this study highlight the importance of domain
cooperativity in the metastable Env and identify key resi-
dues that affect progression in the viral entry pathway. This
is exemplified by the cold sensitivity of mutations resulting
from the deletions of S39 and P40 in the SU N-terminus,
and point mutations to V421 in the SU C-terminus and
G541 in the TM ectodomain. Cooperativity between the
residues, however, restores Env function and viral entry.
Second-site changes in the RBD map to one face
Using the Fr-MuLV RBD as the base molecule (1aol.
pdb) (Fass et al., 1997), the RBD of M-MuLV was modeled.
Second-site changes A60T, V58A, 1255T, and N261I lo-
cated within the M-MuLV RBD are highlighted in Fig. 4A
(left panel). Each change is located within -strands that
comprise the conserved scaffolding structure of the RBD.
Residue A60, positioned on the 2-strand, and N261I (9)
are surface accessible in the monomeric (Fig. 4A, left panel)
and trimeric RBD (data not shown) (Fass et al., 1997).
Mutations at neighboring residues R256 and R258 resulted
in the loss of processing of the SU-TM precursor; however,
viral particles maintained their infectivity (Zavorotinskaya
and Albritton, 1999a). Our previous analysis of the surface
Fig. 4. Location of second-site changes on resolved structural domains of MuLV Env. (A) RBD. Second-site changes detected in EA and AE chimeric Env
viral populations (Lu and Roth, 2003; O’Reilly and Roth, 2000) are highlighted in purple in space-filling representations of modeled M-MuLV and 4070A
RBDs. Models are based on homology to the RBD of Fr-MuLV (1aol.pdb) (Fass et al., 1997). Amino acids are numbered from the initiation methionine of
each Env precursor (B). Map of all second-site changes in chimeric Env viral populations. Compilation of all positions at which second-site changes occurred,
as viewed on the front face of the M-MuLV RBD (left panel) and the rear face (right panel). Changes identified in the 4070A RBD (A, right panel) are
represented by their M-MuLV homologues: M-MuLV N46 (4070A N40); M-MuLV E50 (4070A R44); M-MuLV R56 (4070A G51); M-MuLV P87 (4070A
E80); M-MuLV G166 (4070A G122); M-MuLV T235 (4070A G209) (C). Ectodomain of M-MuLV; M-MuLV residue G552 is highlighted in red in a
space-filling representation of a limited portion of the ectodomain of TM (1mof.pdb) (Fass et al., 1996). It is homologous to the 4070A Env residue G541,
found changed to R in the chimeric populations of EA6 and EA7 and wt 4070A passaged in a canine D17 osteosarcoma cell line (O’Reilly and Roth, 2000).
Neighboring amino acids are highlighted in blue.
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charges in the Fr-RBD identified these amino acids within a
highly basic region distinct from the modeled surface of
4070A (O’Reilly and Roth, 2000). The two minor species
within EA5 viral populations, V58A (2) and 1255T (9),
are buried and have no effect on the viral infection kinetics
relative to the parental EA5 Env (data not shown).
The analysis of the opposing chimeric-enveloped series
(AE series) identified second-site changes in multiple do-
mains of the MuLV Env (Lu and Roth, 2003; O’Reilly and
Roth, 2000). Second-site changes identified within the
4070A RBD domain of chimeric viruses AE4, AE5, and
AE6 are summarized in Fig. 4A (right panel). A comparison
of the left and right panels of Fig. 4A shows that in both
chimeric series, changes in the RBDs map to a common face
of the protein. Fig. 4B represents a merging of all second-
site changes in our analyses of chimeric Envs on the RBD
model of M-MuLV, where 4070A residues are represented
as their M-MuLV homologues (for example: 4070A G122
M-MuLV G166). The changes encompass a broad spatial
area on one face of the RBD, spanning from the top to the
bottom and side to side of the RBD (left panel). With the
exception of residues T235 (4070A G209) and A60, which
protrude slightly from the sides of the RBD, most residues
are not visible on the opposing rear face (Fig. 4B, right
panel). Env variants of bovine leukemia virus (BLV) were
recently characterized (Johnston et al., 2002). The majority
of mutations mapped to one face of the RBD and could be
further defined by neutralizing monoclonal antibodies, lead-
ing to a proposal that this face is solvent exposed. The
opposing side would thus orient itself inward in the Env
complexes. Based on the BLV model, the changes we ob-
serve in the chimeric Envs map to the inward-facing side.
Since the chimeric Envs were constructed with junctions in
the C-terminus, this data, in conjunction with our previous
RBD surface charge analyses, suggest that this surface is
critical for N- and C-terminus interactions within one mono-
mer or for interactions between monomers in the assembled
Env oligomer.
Irreversible cold-sensitive phenotype identifies an
alternative conformation
The characterization of cold-sensitive P22 bacteriophage
coat mutants led to a proposal that a protein’s ability to
achieve multiple conformations requires an incompletely
folded precursor state (Galisteo et al., 1995; Gordon and
King, 1993). The P22 bacteriophage coat protein is pro-
posed to undergo several conformational changes during its
assembly to its final multimeric form (Galisteo et al., 1995).
The concept of viral proteins existing in multiple confor-
mations extends to Env proteins of retroviruses and influ-
enza. Hemagglutinin undergoes major structural rearrange-
ments from its prefusogenic to postfusogenic forms (Carr et
al., 1997; Carr and Kim, 1993, 1994). Additional confor-
mational intermediates have been proposed for the HA2
subunit of the metastable hemagglutin during its low-pH
induced transitions (Hernandez et al., 1996). A recent mu-
tagenesis analysis of HIV-1 Env has identified the existence
of distinct conformations based on antibody recognition
studies (Xiang et al., 2002).
The cold-sensitive mutants in MuLV Env confirm the
existence of multiple conformations and identify the posi-
tions critical for progression to the fusion stage in the
metastable pathway. In the current study, the viral titer was
irreversibly affected by incubation of virus on ice for 30 min
prior to infection. This incubation was previously viewed as
routine. We do not know how widespread the cold-sensi-
tivity phenotype is among the chimeric or mutated Env
viruses. In the present analysis, the N- and C-terminus of
SU, together with the ectodomain of TM, are critical for the
ordered entry process, based on the behavior of the del S39
P40, V421M, and G541R mutants. Fr-MuLV homologues
of M-MuLV residues S39 and P40 were not included in the
resolved structure of Fr-MuLV RBD (Fass et al., 1997), so
structural contacts to the RBD are unknown. S39 and P40
are proximal, however, to the N-terminal M-MuLV H41
residue, which has been shown to be critical for fusion (Bae
et al., 1997; Lavillette et al., 2000; Zavorotinskaya and
Albritton, 1999b). A linker-insertion mutagenesis strategy
has also identified H41 neighboring residues 42–46 and P40
to be critical for fusion (Rothenberg et al., 2001). Ampho-
tropic residue V421 lies to the C-terminus of the conserved
disulfide loop previously identified as critical for SU N- and
C-terminus interactions (Lavillette et al., 2001).
The reversible chemical nature of disulfide bonds leads
to the prediction that the Env protein may exist in two states
on the virus (Sanders, 2000). In one state, the SU–TM
interactions are mediated solely by noncovalent interactions
(Fig. 5A). In the second state, the SU–TM interactions are
further stabilized by a disulfide bond (Fig. 5B). At 37°C and
the proper oxidizing/reducing conditions, the conformation
of Env could be in flux between these states. With the
further assumption that the metastable Env undergoes mul-
tiple conformational changes comes a corollary that confor-
mations may be trapped by the incorporation of stabilizing
mutations in the Env protein. For the retroviral Envs con-
taining any of the single substitutions, incubation at 4°C
could limit entropic freedom of motion and lock the enve-
lope proteins in an early conformation that is unfavorable
for either receptor binding or fusion (Fig. 5E). In a role
analogous to H17 in hemagluttinin, H41 has been proposed
to interact with the fusion peptide of TM (Rothenberg et al.,
2001; C.-W. Lu and M.J. Roth, manuscript in preparation).
The deletion of the H41-proximal residues S39 and P40 has
the potential to alter the context of H41 and thereby affect
interactions with SU and/or TM. Higher temperatures of 25
or 37°C would be favorable for freedom of motion, allow-
ing the Env to achieve multiple conformations despite al-
tered contacts.
Amphotropic residue G541 (M-MuLV G552) is located
within a highly conserved portion of the TM ectodomain
and is N-terminal to the cysteine involved in SU–TM di-
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Fig. 5. Model of domain cooperativity. (A, B, and C) The wild-type MuLV Env can exist in flux between two conformations: one mediated solely by
noncovalent interactions between SU and TM (A), and one mediated additionally by a covalent disulfide bond via one cysteine within the SU CWLC motif
and a cysteine in TM (B). In the proper conformation, the wild-type MuLV Env is able to undergo conformational changes necessary for fusion (C). (D)
Chimeric junctions 5 and 6 within the SU C-terminus alter positioning of the C-terminus of SU relative to the PRR and TM. This altered interaction translates
into altered recognition of TM by the TM monoclonal antibody 42–114. The ectodomain of TM inclusive of cysteines is depicted in an alternate conformation.
Within an EA5 chimeric Env, position E311 (highlighted with a star) helps to compensate for the altered interactions, returning the Env conformation to that
of wild-type Env (A and B). In the case of an EA6 chimeric Env, the return to a wild-type conformation is achieved by cooperative interactions between
E311 and a second mutation, N261I (highlighted with a star), located at the base of the SU RBD. The additional mutation G541R (black star) helps to further
promote wild-type interactions. (E) Chimeric junction 7 within the SU C-terminus results in altered SU–TM interactions and subsequent defects in viral entry.
Envs bearing the single substitutions of del S39 P40 (depicted as altered H41; white star outlined with black) and V421M and G541R (highlighted with black
stars) require freedom of motion (promoted by 37°C and repressed by 4°C) to achieve an Env conformation capable of progressing to fusion (A and B). Envs
bearing G541R in combination with either del S39 P40 or V421M are conformationally stable (B) and their fusion abilities are unaffected by temperature
conditions.
345L. O’Reilly, M.J. Roth / Virology 312 (2003) 337–349
sulfide linkage (Fig. 4C). Curiously, the presence of G541R
in cis with either the del S39 P40 or the V421M mutations
suppresses the cold-sensitive phenotype and leads to in-
creased levels of viral SU protein (Fig. 3A, lanes 5 and 12).
This data suggest a stabilizing interaction between SU and
TM is not only required for assembly (Gray and Roth, 1993;
Pinter et al., 1997), but is a prerequisite for conformational
changes that lead to fusion (Fig. 5B). This is consistent with
the requirement of concerted interactions during fusion ac-
tivation (Barnett et al., 2001, 2003; Lavillette et al., 2000,
2002) and the identification of a stabilizing interaction be-
tween the N-terminus of SU with a C-terminus disulfide
loop (Lavillette et al., 2001). Amphotropic residue G541R
was additionally identified as a key regulatory position for
cell–cell fusion (L. O’Reilly and M.J. Roth, submitted for
publication). The presence of G541R altered the conforma-
tion of the SU C-terminus. The SU protein in viruses with
G541R substitutions could not be recognized by a C-termi-
nus-specific monoclonal antibody (83A25) (Evans et al.,
1990), yet could be recognized by polyclonal antibodies to
SU (80S-019, Microbiological Associates). The EA7 virus
has a junction in the C-terminus of SU close in primary
sequence to the proposed epitope of SU monoclonal anti-
body 83A25 (Rothenberg et al., 2001), and it is likely that
the C-terminal domain contacts with the remaining SU and
TM are altered. In total, the selection of G541R in the EA7
chimeric virus is a key determinant for repairing aberrant
C-terminus interactions and conformations.
Alternative conformations promoted by domain
cooperativity
The introduction of junctions in the C-terminus of SU
between the M-MuLV and 4070A Envs led to viruses that
were impaired in viral passage. For chimeras possessing
junctions 5 and 6, viral Env function was partially restored
by the acquisition of second-site changes at ecotropic resi-
due E311. The E311 residue is located three amino acids to
the C-terminus of the PRR and close to junction 5. The
analysis of viral Env proteins with E311 substitutions
proved very enlightening. Each mutation increased the
amount of TM protein detectable on the virus in comparison
to the parental chimeras using TM monoclonal antibody
42–114. This data suggest E311 affects positioning of the
C-terminus relative to TM. For EA5, E311 mutations sub-
sequently restore TM to a conformation recognizable by
TM antibody 42–114, suggesting that local interactions of
the PRR with the C-terminus of SU is one determinant of
Env conformation within the monomer and/or oligomer.
This is reflected in Figs. 5D, A, and B. Fig. 5D depicts a
misaligned SU C-terminus relative to TM, and the subse-
quent altered conformation of the ectodomain of TM in the
vicinity of the intramolecular disulfide bond and the free
cysteine. SU–TM interactions are restored to those found in
the wild-type Env by the presence of the second-site change
at position E311 (Fig. 5A).
In the case of an EA6 chimera, E311 substitutions repair
the parental chimer in a manner similar to that of EA5. This
effect could be further enhanced by the presence in cis of
the RBD mutation N261I and is reflected in the increased
titer observed for this double-mutant relative to the single
E311 substitution (Table 1: 2.4  104 and 1.2  104,
respectively). The increased titer and conformational differ-
ence observed in the N261I/E311V EA6 mutant virus there-
fore reflects cooperation between the RBD and the C-ter-
minus (Fig. 5B). In EA6, additional regulation is provided
by the subsequent acquisition of G541R in TM.
Our understanding of the events in the ordered viral entry
pathway will require a concerted approach of both muta-
tional and structural analyses. Despite the high degree of
conservation between the M-MuLV and 4070A SU C-ter-
minus, chimeric junctions within this region of Env have
profound effects on the assembly of the SU/TM complex
and subsequent Env conformational changes required for
viral entry. The structure of the SU C-terminus is currently
unsolved. Stabilizing second-site changes, such as those
identified in this study, may assist in trapping one of the
conformations of the SU C-terminus. The identification of
structural intermediates may be further assisted by the pres-
ence of N-terminal TM peptides.
Materials and methods
Cell lines and maintenance
The generation and maintenance of the canine D17/pJET
and the canine D17/gag-pol cell lines has been previously
described (O’Reilly and Roth, 2000).
DNA and plasmids
Chimeric proviral DNA clones (Peredo et al., 1996) and
plasmid pNCA-C expressing the infectious M-MuLV pro-
virus (Felkner and Roth, 1992) were previously described.
Plasmids pHIT 123, pHIT 456, and pHIT111 (Soneoka et
al., 1995) and pHIT 123-Nhe and pHIT 456-Nhe were as
previously described (O’Reilly and Roth, 2000; Thomas et
al., 1997). All DNA used in transfections were purified by
CsCl2 banding. Nucleotide positions are based on the RNA
sequence of M-MuLV defined by Shinnick et. al. (1981).
The 4070A amphotropic envelope sequence is numbered by
the system of Ott and Rein (Ott et al., 1990).
Transient transfections
Transient transfections of proviral DNAs into D17/pJET
cells using DEAE-dextran were as previously described
(Peredo et al., 1996). Transfections to test the parental
chimeric envelope constructs and the reconstructed second-
site changes were performed at least twice. Transfections of
Env expression plasmids using lipofectamine (Gibco-BRL)
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were performed as previously described (O’Reilly and
Roth, 2000).
RT assays
The presence of virus was monitored by the release of
reverse transcriptase (RT) into the culture supernatant. The
medium, collected up to day 41, was assayed as previously
described (Goff et al., 1981).
Viral DNA isolation and PCR amplifications
Culture supernatants from viral producer cells, supple-
mented with Polybrene (8 g/ml), were used to infect D17/
pJET cells. Low molecular weight DNA, corresponding to
unintegrated viral DNA, was isolated as previously de-
scribed (Hirt, 1967; O’Reilly and Roth, 2000). PCR reac-
tions were performed to amplify the env gene with primers
within the pol gene and the 3 long terminal repeat of
M-MuLV as previously described (O’Reilly and Roth,
2000).
Sequencing
Sequencing was performed using a PCR-based sequenc-
ing kit (Amplicycle, Perkin–Elmer) on each PCR-amplified
HIRT DNA. Alternatively, sequencing was performed using
Applied Biosystems 377 dye reagents and results were eval-
uated by the Robert Wood Johnson Medical School DNA
Core Facility (Piscataway, NJ). Base changes from wt M-
MuLV and 4070A-MuLV envs were confirmed by sequenc-
ing with primers that read the opposite DNA strand.
Reconstruction cloning
Second-site changes detected in the viable chimeric en-
veloped MuLV populations were subcloned into the respec-
tive proviral parental DNA. In cases where more than one
second-site change was found in a viral population, each
change was reconstructed singly and in combination with
the parental backbone. All restriction fragments were iso-
lated by agarose gel electrophoresis, purified by glass milk-
based protocols (Vogelstein and Gillespie, 1979) (except
where noted), and ligated with T4 DNA ligase. Amino acids
are denoted by single-letter code and the positions are based
on M-MuLV and 4070A Env precursor proteins. The sec-
ond-site mutations were cloned as described below for each
chimeric viral population.
(i) EA5 reconstructions
The single A60T and A60T/E311K double mutant were
constructed by the ligation of the 1360-bp SfiI-HindIII frag-
ment from the PCR-amplified env fragment with the
5510-kb HindIII-EcoRI and 6000-kb EcoRI-SfiI fragments
derived from parental EA5 DNA. The E311K clone was
generated by the ligation of the 3961-bp BspEI-EcoRI frag-
ment from the A60T/E311K double clone with the 7106-bp
BspEI-EcoRI fragment from the EA5 parental DNA.
(ii) EA6 reconstructions
Second-site changes detected in EA6 viral populations
were reconstructed within the EA6 proviral backbone. The
single-mutation N261I and the double-mutation N261I/
E311V were each cloned by the ligation of the 1360-bp
SfiI-HindIII fragment from the EA6/PCR-derived env frag-
ment with the 782-bp HindIII-ClaI and 8945-bp SfiI-ClaI
fragments of the EA6 parental DNA. The double N261I/
E311V mutant was used to generate the single E311V
mutant. The 5990-bp DraIII-XhoI fragment from the N261I/
E311V mutant was ligated to the 927-bp PmlI-DraIII and
4170-bp PmlI-XhoI fragments from p-NCA-C.
(iii) EA7 reconstructions
The N-terminus deletion mutations of S39 and P40 (del
S39 P40) were reconstructed by the ligation of the 1128-bp
SfiI-BspEI fragment from the PCR-amplified HIRT DNA
(Population A in Table 2) with the 9987-bp SfiI-BspEI
fragment from parental EA7. The single V-to-M mutation at
residue 421 was reconstructed by the ligation of the 1170-bp
BspEI-ClaI fragment from the PCR-amplified HIRT DNA
(Population B in Table 2) and 9917-bp BspEI-ClaI fragment
of the parental EA7 DNA. The single mutation at position
G541 was reconstructed by the ligation of the 1170-bp
BspEI-ClaI fragment from the PCR-amplified DNA of re-
passaged population A (Table 2) with the 9917-bp BspEI-
ClaI fragment of the parental EA7. The double mutation of
V421M and G541R was constructed by the ligation of the
1170-bp BspEI-ClaI I fragment from the PCR-amplified
DNA of the repassaged population B (Table 2) with the
9917-bp BspEI-ClaI fragment from the parental EA7 DNA.
The combination mutant of the N-terminus deletion with
either the single V421M or the G541R was constructed by
the ligation of the 9917-bp BspEI-ClaI fragment of the del
S39 P40 mutant with the 1170-bp BspEI-ClaI fragment
from the respective single mutant.
(iv) Converse E311 constructions
Within EA6 constructs, the AccI (GTAGAC) site was
mutated to a SalI (GTCGAC) site to exchange the E311
substitutions (E311K in EA6 and E311V in EA5). Primer
1557 (5 GGCTCCGTCGACTAAG 3; M-MuLV bases
6737–6722) and primer 6830 (5 GCAACACTGCCTG-
GAAC 3; M-MuLV bases 6160–6176) were used to PCR
amplify a 600-bp fragment (2.5 U PFU polymerase) using
pNCA-C/EA6 containing the E311V mutation. The PCR
product was gel-isolated, purified by a Bio-Rad Freeze-n-
Squeeze column, and ligated into the SmaI site of the vector
pTZ18U (USB). The 200-bp BspEI-SalI fragment from the
pTZ18U clone was ligated with the 900-bp ClaI-SalI and
9960-bp ClaI-BspEI fragments of EA5/pNCA-C to make
the E311V/EA5 proviral clone.
To construct E311K/EA6, primers 7607 (5 CCATGCT-
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GTCTCTCACTAGC 3; 4070A bases 1732–1713) and
19806 (5 CTAAACTTAGTCGACGGAGCC 3; M-MuLV
bases 6719–6739) were used to amplify a 800-bp fragment
using EA6 as a template. The PCR product was ligated into
the vector pTZ18U. The 550-bp BamHI-XbaI fragment
from the pTZ18U-PCR clone was then replaced with the
850-bp BamHI-NheI fragment from the proviral EA6 DNA.
Finally, a 941-bp SalI-ClaI fragment from this clone was
ligated with the 1320-bp Sfi-SalI fragment from proviral
EA5/E311K mutant and the 8795-bp ClaI-SfiI fragment
from proviral EA5 to make the E311K/EA6 proviral con-
struct.
(v) Reconstruction into pHIT123-Nhe vector
The parental env chimeras and second-site changes were
reconstructed into the pHIT 123-Nhe Env expression vector
by replacing the wt M-MuLV 2100-bp PmlI-NheI fragment
with the same fragment from the mutant proviral DNA
clones.
Determination of viral titer
Env expression plasmids and pHIT111 were transfected
into D17/gag-pol cells using the lipofectamine transfection
protocol described above. Infections and staining for -gal
expression were performed as previously described
(O’Reilly and Roth, 2000; Peredo et al., 1996). Titers for
proviral constructs were determined as described above,
except DNAs were transiently transfected into the canine
D17 cell line. Viral supernatants of EA7 chimeric viruses
were divided into three aliquots prior to infections; one
aliquot was used immediately to infect D17/pJET cells,
while the remaining two aliquots were held on ice (4°C) and
at room temperature (25°C) for 30 min prior to infecting
D17/pJET cells at 37°C.
Env protein analyses
Envelope proteins were transiently expressed in either
D17 or D17/gag-pol cells by the lipofectamine transfection
protocol described above. Metabolic labelings with 35S-
Translabel (ICN) were performed as previously described
(Felkner and Roth, 1992). Culture supernatants were har-
vested 12–18 h postlabeling, filtered through an Acrodisc
filter (0.45-m pore size), and applied to a 20% sucrose
cushion. Samples were spun at 35K rpm in a SW41 rotor for
4 h. Pelleted virus was resuspended in phosphate lysis
buffer (PLB) (10 mM Na2HPO4-Na2H2PO4 [pH 7.4], 100
mM NaCl, 0.1% sodium dodecyl sulfate, 0.5% deoxy-
cholate, 1% Triton X-100). Virus corresponding to one-
quarter of a 100-mm plate was immunoprecipitated with 50
l of antibody 42–114 (anti-TM antiserum) (Pinter et al.,
1982). For Western blot analyses, virus was purified by
centrifuging 1-ml aliquots of culture supernatant (of 5 ml
total) through 0.2 ml 20% sucrose at 16K g for 45 min (Wu
et al., 1998) at either 4 or 25°C. For further analyses of EA7
viral Envs, 1-ml aliquots of each virus was alternatively
spun at 3K g for 6 h in the absence of sucrose at 4°C.
Proteins were separated by sodium dodecyl sulfate–polyac-
rylamide electrophoresis (SDS–PAGE). Proteins were
transferred to PVDF membranes using a liquid transfer
system. Polyclonal antibodies 79S-842 (EA5 and EA6
Envs) and 80S-019 (EA7 Envs) (anti-SU antiserum) (Mi-
crobiological Associates) were used to detect Env proteins
by Western blots. Secondary antibody, rabbit -goat IgG
(biotinylated), and avidin-biotin detection system was ob-
tained from Vector Laboratory Systems. Alternatively, Env
proteins were detected using the secondary antibody rabbit-
-goat IgG-HRP and chemiluminescence reagents (Pierce).
Molecular weight markers were obtained from Bio-Rad.
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